Obstructive sleep apnoea and polycystic ovary syndrome:a comprehensive review of clinical interactions and underlying pathophysiology


Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in women of reproductive age. PCOS is associated with multiple comorbidities including, obesity, insulin resistance and type 2 diabetes, as well as mood disorders and impaired quality of life (QoL). Obstructive sleep apnoea (OSA) is also a common medical condition that is often undiagnosed, particularly in women. OSA is associated with a similar spectrum of comorbidities to that observed in PCOS, including manifestations of the metabolic syndrome and impaired QoL, whilst obesity frequently constitutes a common denominator in the pathophysiology of both OSA and PCOS. Hence, it is not surprising that OSA and PCOS may coexist in women of reproductive age, and the current clinical guidelines on the management of PCOS recommend screening for OSA symptoms in overweight/obese women with PCOS. In this review, we examine the relationship between OSA and PCOS and explore the potential underlying mechanisms that link these two conditions.

Publication DOI: https://doi.org/10.1111/cen.13392
Divisions: Aston Medical School
Uncontrolled Keywords: hyperandrogenism,insulin resistance,obesity,obstructive sleep apnoea,polycystic ovary syndrome,Endocrinology, Diabetes and Metabolism
Full Text Link: http://wrap.war ... ck.ac.uk/89743/
Related URLs: http://www.scop ... tnerID=8YFLogxK (Scopus URL)
PURE Output Type: Article
Published Date: 2017-06-22
Published Online Date: 2017-06-22
Accepted Date: 2017-06-08
Authors: Kahal, Hassan
Kyrou, Ioannis ( 0000-0002-6997-3439)
Tahrani, Abd A.
Randeva, Harpal S.

Export / Share Citation


Additional statistics for this record